Close

More on MNPR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.3 Score)

Upcoming Events

- Earnings (5/9/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Monopar Therapeutics (NQ:MNPR)
Delayed: 0.63 -0.03 (4.55%)
Prev. Close $0.66  
Open$0.65 
52 Wk High$ 
52 Wk Low$ 
Day High$0.65 
Day Low$0.62 
P/E N/A  
EPS$ 
Volume58,241 


Apr 18, 2024 08:00 AM Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
Apr 16, 2024 08:13 AM Monopar Therapeutics (MNPR) Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
Apr 16, 2024 08:03 AM Form 8-K Monopar Therapeutics For: Apr 16
Apr 16, 2024 08:01 AM Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
Apr 11, 2024 07:15 AM Jones Trading Upgrades Monopar Therapeutics (MNPR) to Buy on latest MNPR101 data
Apr 10, 2024 08:03 AM Monopar Therapeutics (MNPR) Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
Apr 10, 2024 08:01 AM Form 8-K Monopar Therapeutics For: Apr 10
Apr 10, 2024 08:00 AM Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
Apr 2, 2024 08:36 PM Form 4 Monopar Therapeutics For: Mar 31 Filed by: Cittadine Andrew
Apr 2, 2024 08:34 PM Form 4 Monopar Therapeutics For: Mar 31 Filed by: Tsuchimoto Kim R
View All Articles

Entities mentioned with MNPR

View All Entities